{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T15:03:29Z","timestamp":1762009409119,"version":"build-2065373602"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2018,10,29]],"date-time":"2018-10-29T00:00:00Z","timestamp":1540771200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2019,3]]},"DOI":"10.1007\/s10067-018-4351-4","type":"journal-article","created":{"date-parts":[[2018,10,29]],"date-time":"2018-10-29T14:11:44Z","timestamp":1540822304000},"page":"785-791","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Acceptable quality of life and low disease activity achievable among transition phase patients with rheumatic disease"],"prefix":"10.1007","volume":"38","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8065-3930","authenticated-orcid":false,"given":"Heikki","family":"Relas","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silja","family":"Kosola","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,10,29]]},"reference":[{"key":"4351_CR1","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1016\/S0140-6736(07)60363-8","volume":"369","author":"A Ravelli","year":"2007","unstructured":"Ravelli A, Martini A (2007) Juvenile idiopathic arthritis. Lancet 369:767\u2013778","journal-title":"Lancet"},{"key":"4351_CR2","first-page":"2275","volume":"30","author":"L Berntson","year":"2003","unstructured":"Berntson L, Andersson Gare B, Fasth A et al (2003) Incidence of juvenile idiopathic arthritis in the Nordic countries. A population based study with special reference to the validity of the ILAR and EULAR criteria. J Rheumatol 30:2275\u20132282","journal-title":"J Rheumatol"},{"key":"4351_CR3","doi-asserted-by":"crossref","unstructured":"Hersh A, von Scheven E, Yelin E, Medscape (2011) Adult outcomes of childhood-onset rheumatic diseases. Nat Rev Rheumatol 7:290\u2013295","DOI":"10.1038\/nrrheum.2011.38"},{"key":"4351_CR4","doi-asserted-by":"publisher","first-page":"2155","DOI":"10.1093\/rheumatology\/keu257","volume":"53","author":"EJ Coulson","year":"2014","unstructured":"Coulson EJ, Hanson HJ, Foster HE (2014) What does an adult rheumatologist need to know about juvenile idiopathic arthritis? Rheumatology (Oxford) 53:2155\u20132166","journal-title":"Rheumatology (Oxford)"},{"key":"4351_CR5","doi-asserted-by":"publisher","first-page":"2809","DOI":"10.1002\/art.30426","volume":"63","author":"E Nordal","year":"2011","unstructured":"Nordal E, Zak M, Aalto K, Berntson L, Fasth A, Herlin T, Lahdenne P, Nielsen S, Straume B, Rygg M, Nordic Study Group of Pediatric Rheumatology (2011) Ongoing disease activity and changing categories in a long-term nordic cohort study of juvenile idiopathic arthritis. Arthritis Rheum 63:2809\u20132818","journal-title":"Arthritis Rheum"},{"key":"4351_CR6","doi-asserted-by":"publisher","first-page":"715","DOI":"10.3899\/jrheum.120602","volume":"40","author":"L Bertilsson","year":"2013","unstructured":"Bertilsson L, Andersson-Gare B, Fasth A, Petersson IF, Forsblad-D'elia H (2013) Disease course, outcome, and predictors of outcome in a population-based juvenile chronic arthritis cohort followed for 17 years. J Rheumatol 40:715\u2013724","journal-title":"J Rheumatol"},{"key":"4351_CR7","doi-asserted-by":"publisher","first-page":"520","DOI":"10.3899\/jrheum.121013","volume":"40","author":"M Elhai","year":"2013","unstructured":"Elhai M, Bazeli R, Freire V, Feydy A, Drape JL, Quartier P, Kahan A, Deslandre C, Wipff J (2013) Radiological peripheral involvement in a cohort of patients with polyarticular juvenile idiopathic arthritis at adulthood. J Rheumatol 40:520\u2013527","journal-title":"J Rheumatol"},{"key":"4351_CR8","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1007\/s00296-008-0673-x","volume":"29","author":"K Laas","year":"2009","unstructured":"Laas K, Roine R, Rasanen P, Sintonen H, Leirisalo-Repo M, HUS QoL Study Group (2009) Health-related quality of life in patients with common rheumatic diseases referred to a university clinic. Rheumatol Int 29:267\u2013273","journal-title":"Rheumatol Int"},{"key":"4351_CR9","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0153267","volume":"11","author":"S Barth","year":"2016","unstructured":"Barth S, Haas JP, Schlichtiger J, Molz J, Bisdorff B, Michels H, H\u00fcgle B, Radon K (2016) Long-term health-related quality of life in German patients with juvenile idiopathic arthritis in comparison to German general population. PLoS One 11:e0153267","journal-title":"PLoS One"},{"key":"4351_CR10","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1002\/art.10863","volume":"48","author":"HE Foster","year":"2003","unstructured":"Foster HE, Marshall N, Myers A, Dunkley P, Griffiths ID (2003) Outcome in adults with juvenile idiopathic arthritis: a quality of life study. Arthritis Rheum 48:767\u2013775","journal-title":"Arthritis Rheum"},{"key":"4351_CR11","doi-asserted-by":"crossref","unstructured":"Tollisen A, Selvaag AM, Aulie HA et al (2017) Physical functioning, pain and health-related quality of life in adults with juvenile idiopathic arthritis: a longitudinal 30-year follow-up study. Arthritis Care Res (Hoboken)","DOI":"10.1002\/acr.23327"},{"key":"4351_CR12","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.jbspin.2015.03.005","volume":"83","author":"J Wipff","year":"2016","unstructured":"Wipff J, Sparsa L, Lohse A, Quartier P, Kahan A, Deslandre CJ (2016) Impact of juvenile idiopathic arthritis on quality of life during transition period at the era of biotherapies. Joint Bone Spine 83:69\u201374","journal-title":"Joint Bone Spine"},{"key":"4351_CR13","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/1546-0096-12-13","volume":"12","author":"ML Stoll","year":"2014","unstructured":"Stoll ML, Cron RQ (2014) Treatment of juvenile idiopathic arthritis: a revolution in care. Pediatr Rheumatol Online J 12:13. \n                    https:\/\/doi.org\/10.1186\/1546-0096-12-13\n                    \n                   eCollection 2014","journal-title":"Pediatr Rheumatol Online J"},{"key":"4351_CR14","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/S1054-139X(03)00208-8","volume":"33","author":"DS Rosen","year":"2003","unstructured":"Rosen DS, Blum RW, Britto M, Sawyer SM, Siegel DM, Society for Adolescent Medicine (2003) Transition to adult health care for adolescents and young adults with chronic conditions: position paper of the Society for Adolescent Medicine. J Adolesc Health 33:309\u2013311","journal-title":"J Adolesc Health"},{"key":"4351_CR15","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1016\/j.rdc.2007.07.005","volume":"33","author":"LB Tucker","year":"2007","unstructured":"Tucker LB, Cabral DA (2007) Transition of the adolescent patient with rheumatic disease: issues to consider. Rheum Dis Clin N Am 33:661\u2013672","journal-title":"Rheum Dis Clin N Am"},{"key":"4351_CR16","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/1546-0096-8-2","volume":"8","author":"E Hazel","year":"2010","unstructured":"Hazel E, Zhang X, Duffy CM, Campillo S (2010) High rates of unsuccessful transfer to adult care among young adults with juvenile idiopathic arthritis. Pediatr Rheumatol Online J 8:2. \n                    https:\/\/doi.org\/10.1186\/1546-0096-8-2","journal-title":"Pediatr Rheumatol Online J"},{"key":"4351_CR17","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s12969-015-0016-x","volume":"13","author":"E Stringer","year":"2015","unstructured":"Stringer E, Scott R, Mosher D, MacNeill I, Huber AM, Ramsey S, Lang B (2015) Evaluation of a rheumatology transition clinic. Pediatr Rheumatol Online J 13:22. \n                    https:\/\/doi.org\/10.1186\/s12969-015-0016-x","journal-title":"Pediatr Rheumatol Online J"},{"key":"4351_CR18","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1136\/annrheumdis-2016-210112","volume":"76","author":"HE Foster","year":"2017","unstructured":"Foster HE, Minden K, Clemente D, Leon L, McDonagh JE, Kamphuis S, Berggren K, van Pelt P, Wouters C, Waite-Jones J, Tattersall R, Wyllie R, Stones SR, Martini A, Constantin T, Schalm S, Fidanci B, Erer B, Dermikaya E, Ozen S, Carmona L (2017) EULAR\/PReS standards and recommendations for the transitional care of young people with juvenile-onset rheumatic diseases. Ann Rheum Dis 76:639\u2013646","journal-title":"Ann Rheum Dis"},{"key":"4351_CR19","doi-asserted-by":"crossref","unstructured":"Relas H, Luosujarvi R, Kosola S (2018) Outcome of transition phase patients with juvenile idiopathic arthritis. Mod Rheumatol:1\u20136","DOI":"10.1080\/14397595.2017.1416890"},{"key":"4351_CR20","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1002\/art.1780230202","volume":"23","author":"JF Fries","year":"1980","unstructured":"Fries JF, Spitz P, Kraines RG, Holman HR (1980) Measurement of patient outcome in arthritis. Arthritis Rheum 23:137\u2013145","journal-title":"Arthritis Rheum"},{"key":"4351_CR21","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.rdc.2005.09.005","volume":"32","author":"D Aletaha","year":"2006","unstructured":"Aletaha D, Smolen JS (2006) The definition and measurement of disease modification in inflammatory rheumatic diseases. Rheum Dis Clin N Am 32:9\u201344 vii","journal-title":"Rheum Dis Clin N Am"},{"key":"4351_CR22","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1002\/art.1780380107","volume":"38","author":"ML Prevoo","year":"1995","unstructured":"Prevoo ML, van 't Hof MA, Kuper HH, van Leeuwen MA, van de Putte LB, van Riel PL (1995) Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum 38:44\u201348","journal-title":"Arthritis Rheum"},{"key":"4351_CR23","first-page":"2286","volume":"21","author":"S Garrett","year":"1994","unstructured":"Garrett S, Jenkinson T, Kennedy LG, Whitelock H, Gaisford P, Calin A (1994) A new approach to defining disease status in ankylosing spondylitis: the Bath ankylosing spondylitis disease activity index. J Rheumatol 21:2286\u20132291","journal-title":"J Rheumatol"},{"key":"4351_CR24","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1016\/S0140-6736(74)90884-8","volume":"2","author":"EC Huskisson","year":"1974","unstructured":"Huskisson EC (1974) Measurement of pain. Lancet 2:1127\u20131131","journal-title":"Lancet"},{"key":"4351_CR25","doi-asserted-by":"publisher","first-page":"328","DOI":"10.3109\/07853890109002086","volume":"33","author":"H Sintonen","year":"2001","unstructured":"Sintonen H (2001) The 15D instrument of health-related quality of life: properties and applications. Ann Med 33:328\u2013336","journal-title":"Ann Med"},{"key":"4351_CR26","first-page":"646","volume":"81","author":"AD Woolf","year":"2003","unstructured":"Woolf AD, Pfleger B (2003) Burden of major musculoskeletal conditions. Bull World Health Organ 81:646\u2013656","journal-title":"Bull World Health Organ"},{"key":"4351_CR27","first-page":"S131","volume":"27","author":"G Horneff","year":"2009","unstructured":"Horneff G, Burgos-Vargas R (2009) Juvenile idiopathic arthritis. Subgroup characteristics and comparisons between rheumatoid arthritis-like subgroups and ankylosing spondylitis-like subgroups. Clin Exp Rheumatol 27:S131\u2013S138","journal-title":"Clin Exp Rheumatol"},{"key":"4351_CR28","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1016\/j.semarthrit.2016.10.008","volume":"46","author":"R Davies","year":"2017","unstructured":"Davies R, Gaynor D, Hyrich KL, Pain CE (2017) Efficacy of biologic therapy across individual juvenile idiopathic arthritis subtypes: a systematic review. Semin Arthritis Rheum 46:584\u2013593","journal-title":"Semin Arthritis Rheum"},{"key":"4351_CR29","doi-asserted-by":"publisher","first-page":"460","DOI":"10.3389\/fphar.2017.00460","volume":"8","author":"P Li","year":"2017","unstructured":"Li P, Zheng Y, Chen X (2017) Drugs for autoimmune inflammatory diseases: from small molecule compounds to anti-TNF biologics. Front Pharmacol 8:460","journal-title":"Front Pharmacol"},{"key":"4351_CR30","unstructured":"Smoking in Finland (2018) Available at: \n                    https:\/\/thl.fi\/en\/web\/alcohol-tobacco-and-addictions\/tobacco\/smoking-in-finland"},{"key":"4351_CR31","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1097\/BOR.0b013e32832a2e16","volume":"21","author":"KP Liao","year":"2009","unstructured":"Liao KP, Alfredsson L, Karlson EW (2009) Environmental influences on risk for rheumatoid arthritis. Curr Opin Rheumatol 21:279\u2013283","journal-title":"Curr Opin Rheumatol"},{"key":"4351_CR32","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1097\/BOR.0b013e32801127c8","volume":"19","author":"L Klareskog","year":"2007","unstructured":"Klareskog L, Padyukov L, Alfredsson L (2007) Smoking as a trigger for inflammatory rheumatic diseases. Curr Opin Rheumatol 19:49\u201354","journal-title":"Curr Opin Rheumatol"},{"key":"4351_CR33","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1136\/ard.2010.139212","volume":"70","author":"S Saevarsdottir","year":"2011","unstructured":"Saevarsdottir S, Wallin H, Seddighzadeh M, Ernestam S, Geborek P, Petersson IF, Bratt J, van Vollenhoven RF, for the SWEFOT Trial Investigators Group (2011) Predictors of response to methotrexate in early DMARD naive rheumatoid arthritis: results from the initial open-label phase of the SWEFOT trial. Ann Rheum Dis 70:469\u2013475","journal-title":"Ann Rheum Dis"},{"key":"4351_CR34","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1002\/art.27758","volume":"63","author":"S Saevarsdottir","year":"2011","unstructured":"Saevarsdottir S, Wedren S, Seddighzadeh M et al (2011) Patients with early rheumatoid arthritis who smoke are less likely to respond to treatment with methotrexate and tumor necrosis factor inhibitors: observations from the epidemiological investigation of rheumatoid arthritis and the Swedish rheumatology register cohorts. Arthritis Rheum 63:26\u201336","journal-title":"Arthritis Rheum"},{"key":"4351_CR35","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1111\/j.1521-0391.2014.12148.x","volume":"23","author":"M Goldenberg","year":"2014","unstructured":"Goldenberg M, Danovitch I, IsHak WW (2014) Quality of life and smoking. Am J Addict 23:540\u2013562","journal-title":"Am J Addict"},{"key":"4351_CR36","doi-asserted-by":"publisher","first-page":"e000458","DOI":"10.1136\/rmdopen-2017-000458","volume":"3","author":"A Levitsky","year":"2017","unstructured":"Levitsky A, Brismar K, Hafstrom I et al (2017) Obesity is a strong predictor of worse clinical outcomes and treatment responses in early rheumatoid arthritis: results from the SWEFOT trial. RMD Open 3:e000458. \n                    https:\/\/doi.org\/10.1136\/rmdopen-2017-000458\n                    \n                   eCollection 2017","journal-title":"RMD Open"},{"key":"4351_CR37","unstructured":"Nutrition, Physical Activity and Obesity Finland (2013) Available at:\n                           \n                    http:\/\/www.euro.who.int\/__data\/assets\/pdf_file\/0008\/243296\/Finland-WHO-Country-Profile.pdf"},{"key":"4351_CR38","doi-asserted-by":"publisher","first-page":"286","DOI":"10.3109\/03009742.2013.876512","volume":"43","author":"KJ Aaltonen","year":"2014","unstructured":"Aaltonen KJ, Sokka T, Mottonen T et al (2014) A nationwide cross-sectional overview of patients with rheumatoid arthritis followed in outpatient specialty clinics in Finland. Scand J Rheumatol 43:286\u2013290","journal-title":"Scand J Rheumatol"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10067-018-4351-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-018-4351-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-018-4351-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,29]],"date-time":"2019-10-29T00:23:32Z","timestamp":1572308612000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10067-018-4351-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10,29]]},"references-count":38,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,3]]}},"alternative-id":["4351"],"URL":"https:\/\/doi.org\/10.1007\/s10067-018-4351-4","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"type":"print","value":"0770-3198"},{"type":"electronic","value":"1434-9949"}],"subject":[],"published":{"date-parts":[[2018,10,29]]},"assertion":[{"value":"22 July 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 October 2018","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 October 2018","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 October 2018","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Retrospective data were used, and patients were not contacted for this study. Thus, ethics approval was not required for this study at our institution.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}}]}}